| Patents for C07C 317 - Sulfones; Sulfoxides (15,874) |
|---|
| 05/22/2003 | US20030096818 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/22/2003 | US20030096796 N-cyanomethyl amides which are cysteine protease inhibitors; use treating diseases associated with activity of cathepsins B, K, L or S such as autoimmune disorders, allergic disorder, allogeneic immune response, cardiovascular disorders |
| 05/22/2003 | US20030096257 Solid support for use in the nucleotide sequence analysis |
| 05/22/2003 | CA2466962A1 Aryl aniline beta-2 adrenergic receptor agonists |
| 05/22/2003 | CA2466115A1 Cyanoalkylamino derivatives as protease inhibitors |
| 05/21/2003 | EP1312603A1 Polymerisable bis-sulphonyl derivatives and their use for preparing ion exchange membranes |
| 05/21/2003 | EP1312602A1 Amidino derivatives, and anticoagulants and thrombosis therapeutic agents containing them |
| 05/21/2003 | EP1311476A1 Aza-amino acid derivatives (factor x a?-inhibitors 15) |
| 05/21/2003 | CN1419539A Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 05/21/2003 | CN1419537A Insecticidal anthranilamides |
| 05/21/2003 | CN1419534A Diphenyl ether compounds useful in therapie |
| 05/21/2003 | CN1418870A 3,4-dibidro-1H-anphthalene derivatives used as high selectivity inhibitor of cyclooxygenase-2 |
| 05/20/2003 | US6566547 Fungicides |
| 05/20/2003 | US6566384 For therapy of cancer, inflammation and inflammatory diseases, tissue degeneration, periodontal disease, ophthalmological disease, dermatological disorders, fever, cardiovascular effects, haemorrhage, coagulation and acute phase response |
| 05/20/2003 | US6566381 For therapy of arthritis, cancer, cardiovascular disorder, skin disorder, ocular disorder, inflammation and gum disease |
| 05/20/2003 | CA2197302C Solid support reagents for the synthesis of 3'-nitrogen containing polynucleotides |
| 05/20/2003 | CA2110693C Amino acid derivative anticonvulsant |
| 05/15/2003 | WO2003040096A2 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | WO2003040087A1 Process for the preparation of 2-[alkyl(aryl)]sulfonylbenzene-sulfonyl chlorides and their intermediates |
| 05/15/2003 | WO2002057298A3 C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 05/15/2003 | US20030092941 Aqueous solution containing dihydroxydiphenyl sulfone monoether compound is adjusted pH to a preset value, extracted with an organic solvent and separated to an organic and an aqueous layers, and that water or water adjusted to a fixed pH |
| 05/15/2003 | US20030092762 Anti-inflammatory nitro and thia-fatty acids |
| 05/15/2003 | US20030092715 Aryl and biaryl compounds having MCH modulatory activity |
| 05/15/2003 | US20030092634 Novel compounds and compositions as protease inhibitors |
| 05/15/2003 | CA2466284A1 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/15/2003 | CA2465115A1 Process for the preparation of 2-¢alkyl(aryl)!sulfonylbenzene-sulfonyl chlorides and their intermediates |
| 05/14/2003 | EP1310483A1 Electrophotographic organophotoreceptors with charge transport compounds |
| 05/14/2003 | EP1309573A1 Urethane derivatives |
| 05/14/2003 | EP1309549A1 Acetamide derivatives and the use thereof as inhibitors of coagulation factors xa and viia |
| 05/14/2003 | EP1309547A1 Crystalline and pure modafinil, and process of preparing the same |
| 05/14/2003 | EP1309535A1 A PROCESS FOR THE PREPARATION OF $g(a)' CHLOROKETONES |
| 05/13/2003 | US6563003 Process to produce amino alcohol salts |
| 05/13/2003 | US6563002 Biscyclopropanecarboxamide compounds and pharmaceutical use thereof |
| 05/13/2003 | US6562994 Reacting a substituted halo- or sulfonylbenzene with an alpha, beta unsaturated propanamide; followed by epoxidation, reacting with a thiol and oxidizing; no chromatographic separations; uses less expensive starting materials |
| 05/13/2003 | US6562807 For prophylaxis and therapy of hyperglycemia, Type 1 diabetes, Type 2 diabetes, disorders of the lipid metabolism, such as dyslipidemia, and obesity |
| 05/13/2003 | CA2021467C Heterocyclically substituted sulfonylureas, process for their preparation, and their use as herbicides or plant growth regulators |
| 05/08/2003 | WO2003037854A1 Method of preparing 4-chloro-3-methyl-2-butenylphenyl sulfide, di(4-chloro-3-methyl-2-butenyl)sulfide and di(4-chloro-3-methyl-2-butenyl)sulfone for synthesis of natural carotenoid products |
| 05/08/2003 | WO2003037853A1 Substituted thioacetamides |
| 05/08/2003 | WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors |
| 05/08/2003 | US20030088111 Protected forms of pharmacologically active agents and uses therefor |
| 05/08/2003 | US20030087956 Useful in the treatment of disease mediated by the interaction between VCAM-1 and/or fibronectin and the integrin receptor alpha 4 beta 1. |
| 05/08/2003 | US20030087945 Sulfonylaminocarboxylic acids |
| 05/08/2003 | US20030087905 Containing a haloalkyl group: e.g., 3-((3-(3-trifluoromethoxyphenoxy) phenyl)((3-(1,1,2,2-tetrafluoroethoxy)phenyl)methyl)amino)-1,1,1-trifluoro-2-propanol |
| 05/08/2003 | US20030087897 Containing carboxylic acid groups; diagnosis; prophylaxis |
| 05/08/2003 | CA2462206A1 Substituted thioacetamides |
| 05/07/2003 | EP0889863B1 Surface modified carbonate materials |
| 05/07/2003 | EP0792270B1 Use of 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxy chroman (LLU-alpha) |
| 05/07/2003 | EP0749433B1 (4,4-difluorobut-3-enylthio)-substituted heterocyclic or carbocyclic ring compounds having pesticidal activity |
| 05/07/2003 | EP0749417B1 Cyano compounds and preparations thereof |
| 05/07/2003 | CN1416416A Androgen receptor suppressors in treatment of hirsutism,acne and androgenetic alopecia |
| 05/07/2003 | CN1107672C Intermediate for preparing pyrazole derivatives |
| 05/06/2003 | US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use |
| 05/06/2003 | US6559181 A method to treat endometrial carcinoma, prostate cancer, or prostate hyperplasia comprising administering to a patient in need of such treatment an effective dose of a 3,4-Diphenyl-bicyclo(4.3.0)nonyl compound of formula I |
| 05/02/2003 | EP1306369A1 Novel sulfur compounds and intermolecular compounds containing the same as the component compound |
| 05/02/2003 | EP1306368A2 3,4-dihydro-1H-naphtalene derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 05/02/2003 | EP1305304A1 Carboxamide compounds and their use as antagonists of a human 11cby receptor |
| 05/02/2003 | EP1305301A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 05/02/2003 | EP1305015A1 Substituted styryl benzylsulfones for treating proliferative disorders |
| 05/02/2003 | EP0811006B1 Benzopyran-containing compounds and method for their use |
| 05/01/2003 | US20030083517 Methods of preparing sulfinamides and sulfoxides |
| 05/01/2003 | US20030083505 Benzenedicarboxylic acid derivatives |
| 05/01/2003 | US20030083374 NAALADase inhibitors useful as pharmaceutical compounds and compositions |
| 05/01/2003 | US20030083356 Statine derivatives for the treatment of Alzheimer's disease |
| 05/01/2003 | US20030083341 2,3,5-Substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/01/2003 | US20030083267 For inhibiting the binding of ligands to antigens; prophylaxis and treatment of inflammatory and autoimmune diseases such as asthma, arthritis, psoriasis, transplantation rejection, multiple sclerosis, diabetes, and inflammatory bowel disease |
| 05/01/2003 | US20030082547 Non-fluorescent quencher compounds and biomolecular assays |
| 04/30/2003 | CN1107059C Azole derivative |
| 04/29/2003 | US6555714 P-hydrophenylpyruvate dioxygenases (HPPD) from plants is incubated with test substrate and enzymatic activity of enzyme is determined in comparison with activity of uninhibited enzyme |
| 04/29/2003 | US6555705 Thermosensitive recording material and phthalic acid derivatives for use in the same |
| 04/29/2003 | US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery |
| 04/29/2003 | US6555690 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
| 04/24/2003 | WO2003033461A1 Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 04/24/2003 | US20030078440 O- or S- substituted tetrahydronaphthalene derivatives useful as regulators of cell proliferation and differentiation, useful for treating skin-related diseases |
| 04/24/2003 | US20030078299 Anti-cancer nitro- and thia-fatty acids |
| 04/24/2003 | US20030078267 Oxidation of a dihydro-pyrazolopyridazine |
| 04/24/2003 | CA2464435A1 Synthesis of oxygen-substituted benzocycloheptenes, used as valuable intermediate products for producing tissue-selective oestrogens |
| 04/24/2003 | CA2462442A1 Alkyne matrix metalloproteinase inhibitors |
| 04/23/2003 | EP1304322A2 Carboxylic acid compound and use thereof |
| 04/23/2003 | EP0669978B1 Flk-1 is a receptor for vascular endothelial growth factor |
| 04/23/2003 | CN1413215A Process for preparation of pyrazolo pyridazine derivatives |
| 04/23/2003 | CN1413188A Resolution of intermediates in synthesis of substantially pure bicalutamide |
| 04/23/2003 | CN1106371C Liquid crystal compounds having perfluoroether terminal portions |
| 04/22/2003 | US6552231 Oxidation in aqueous solution |
| 04/17/2003 | WO2003031418A1 3,4-dihydro-1h-naphthalene derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/17/2003 | WO2003031398A1 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/17/2003 | WO2002032226A1 Ectoparasitic insect pest controllers for animals and their usage |
| 04/17/2003 | WO2000037430A3 Use of androgen receptor suppressors |
| 04/17/2003 | US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 04/17/2003 | US20030073742 Using p-fluorobenzenesulfinic acid |
| 04/17/2003 | US20030073712 Antiinflamamtory agents; antiischemic agents |
| 04/17/2003 | US20030073685 Nitric oxide synthase inhibitor; antiinflammatory agents |
| 04/16/2003 | EP1302468A1 Processes and intermediates for manufacturing retroviral protease inhibiting compounds |
| 04/16/2003 | EP1301458A1 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis |
| 04/16/2003 | EP1301275A1 Composition and compound based on metal and acid salt(s) having a sulphonyl group borne by a perhalogenated carbon and their use as lewis acid |
| 04/16/2003 | EP0998451B1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 04/16/2003 | CN1411453A Trans olefinic glucokinase activators |